Reuters: Oramed Says Oral Insulin Succeeds in Midstage Type 2 Diabetes Trial

http://www.reuters.com/article/us-oramed-insulin-idUSKCN0Y91F2

You may also be interested

Market Exclusive: Weekly Biotech Report Part II, Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)
Linkedin-in Facebook-f Twitter Youtube

Copyright © 2022 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy

Join our mailing list

Linkedin-in Facebook-f Twitter Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Annual shareholder meeting
Investor Relations
SEC filings
Investor FAQ
Governance documents
Investor tools
Oravax Medical
Skip to content